These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28474719)

  • 21. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
    Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
    Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of [¹¹C]Cimbi-806 as a potential PET ligand for 5-HT₇ receptor imaging.
    Herth MM; Hansen HD; Ettrup A; Dyssegaard A; Lehel S; Kristensen J; Knudsen GM
    Bioorg Med Chem; 2012 Jul; 20(14):4574-81. PubMed ID: 22682922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current radiosynthesis strategies for 5-HT2A receptor PET tracers.
    Herth MM; Knudsen GM
    J Labelled Comp Radiopharm; 2015 Jun; 58(7):265-73. PubMed ID: 25997728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.
    Ettrup A; Holm S; Hansen M; Wasim M; Santini MA; Palner M; Madsen J; Svarer C; Kristensen JL; Knudsen GM
    Mol Imaging Biol; 2013 Aug; 15(4):376-83. PubMed ID: 23306971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concise and Scalable Radiosynthesis of (+)-[
    Chavan LN; Voll R; Sanchez MM; Nye JA; Goodman MM
    ACS Chem Neurosci; 2023 Oct; 14(19):3694-3703. PubMed ID: 37748194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.
    Märcher Rørsted E; Jensen AA; Kristensen JL
    ChemMedChem; 2021 Nov; 16(21):3263-3270. PubMed ID: 34288515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spirocyclic Iodonium Ylides for Fluorine-18 Radiolabeling of Non-Activated Arenes: From Concept to Clinical Research.
    Chassé M; Pees A; Lindberg A; Liang SH; Vasdev N
    Chem Rec; 2023 Sep; 23(9):e202300072. PubMed ID: 37183954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain.
    Yanamoto K; Kumata K; Yamasaki T; Odawara C; Kawamura K; Yui J; Hatori A; Suzuki K; Zhang MR
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1707-10. PubMed ID: 19217778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo PET Imaging of [11C]CIMBI-5, a 5-HT2AR Agonist Radiotracer in Nonhuman Primates.
    Prabhakaran J; DeLorenzo C; Zanderigo F; Knudsen GM; Gilling N; Pratap M; Jorgensen MJ; Daunais J; Kaplan JR; Parsey RV; Mann JJ; Kumar D
    J Pharm Pharm Sci; 2019; 22(1):352-364. PubMed ID: 31356761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photoswitchable TCB-2 for control of the 5-HT
    Esmaeili AJ; Montazeri P; Gomez JC; Dumervil DJ; Nezhad FS; Steinhardt RC
    Chem Commun (Camb); 2024 Oct; 60(83):11956-11959. PubMed ID: 39350732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorinated diaryl sulfides as serotonin transporter ligands: synthesis, structure-activity relationship study, and in vivo evaluation of fluorine-18-labeled compounds as PET imaging agents.
    Huang Y; Bae SA; Zhu Z; Guo N; Roth BL; Laruelle M
    J Med Chem; 2005 Apr; 48(7):2559-70. PubMed ID: 15801845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging.
    Debus F; Herth MM; Piel M; Buchholz HG; Bausbacher N; Kramer V; Lüddens H; Rösch F
    Nucl Med Biol; 2010 May; 37(4):487-95. PubMed ID: 20447561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain.
    Fujinaga M; Yamasaki T; Yui J; Hatori A; Xie L; Kawamura K; Asagawa C; Kumata K; Yoshida Y; Ogawa M; Nengaki N; Fukumura T; Zhang MR
    J Med Chem; 2012 Mar; 55(5):2342-52. PubMed ID: 22316010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging.
    Lemoine L; Becker G; Vacher B; Billard T; Lancelot S; Newman-Tancredi A; Zimmer L
    J Nucl Med; 2012 Jun; 53(6):969-76. PubMed ID: 22577236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptor.
    Jackson A; Battle MR; O'Shea DM; Chau WF; Gaeta A; Brown SL; Ewan AL; Jones CL; Jones PA; Woodcraft JL; Bouvet DR; Guilbert BB; Trigg W
    Nucl Med Biol; 2014 Feb; 41(2):196-202. PubMed ID: 24480268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, biological evaluation and radiolabelling by 18F-fluoroarylation of a dopamine D3-selective ligand as prospective imaging probe for PET.
    Höfling SB; Maschauer S; Hübner H; Gmeiner P; Wester HJ; Prante O; Heinrich MR
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6933-7. PubMed ID: 21030255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfonium salts as leaving groups for aromatic labelling of drug-like small molecules with fluorine-18.
    Sander K; Gendron T; Yiannaki E; Cybulska K; Kalber TL; Lythgoe MF; Årstad E
    Sci Rep; 2015 Apr; 5():9941. PubMed ID: 25898175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
    Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
    J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overcoming Depression with 5-HT
    Zięba A; Stępnicki P; Matosiuk D; Kaczor AA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.